BlueSky Immunotherapies GmbH: Equine Sarcoids - visible success with delNS-based immunotherapy leads the way towards cancer therapy in humans
VIENNA, Dec. 10, 2021 /PRNewswire/ -- Scientists from the Viennese biotech company BlueSky Immunotherapies GmbH (Ltd.) have used their viral vector platform delNS to treat sarcoids in horses.